loxoprofen has been researched along with Nephrosis, Lipoid in 2 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
Nephrosis, Lipoid: A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanazawa, H | 1 |
| Kotoda, A | 1 |
| Akimoto, T | 1 |
| Shinozaki, T | 1 |
| Inoue, M | 1 |
| Sugimoto, H | 1 |
| Kusano, E | 1 |
| Kikuchi, H | 1 |
| Aoyagi, M | 1 |
| Nagahama, K | 1 |
| Yajima, Y | 1 |
| Yamamura, C | 1 |
| Arai, Y | 1 |
| Hirasawa, S | 1 |
| Aki, S | 1 |
| Inaba, N | 1 |
| Tanaka, H | 1 |
| Tamura, T | 1 |
2 other studies available for loxoprofen and Nephrosis, Lipoid
| Article | Year |
|---|---|
Serial Tc-99m MAG3 renography evaluating the recovery of acute kidney injury associated with minimal change nephrotic syndrome.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents, Non-Steroidal; Disease Susceptibility; Fracture | 2013 |
Nephrotic-range proteinuria and interstitial nephritis associated with the use of a topical loxoprofen patch.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Kidney; Neph | 2014 |